Corpus Intelligence IC Memo — FREEDOM BEHAVIORAL HOSPITAL OF TOPEK 2026-04-26 09:55 UTC
IC Memo — FREEDOM BEHAVIORAL HOSPITAL OF TOPEK
Investment Committee Memorandum | KS | 24 beds | Grade D | EBITDA uplift $205K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

FREEDOM BEHAVIORAL HOSPITAL OF TOPEK

CCN 174021 | SHAWNEE, KS | 24 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

FREEDOM BEHAVIORAL HOSPITAL OF TOPEK is a 24-bed community hospital in SHAWNEE, KS with $2.6M in net patient revenue and a -32.9% operating margin. The hospital serves a payer mix of 35.8% Medicare, 0.0% Medicaid, and 64.2% commercial.

Thesis: Turnaround. Our ML models identify $205K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -32.9% to -25.0% (+793bps).

Net Revenue HCRIS$2.6M
Current EBITDA COMPUTED$-852K
Operating Margin COMPUTED-32.9%
Occupancy HCRIS36.5%
Revenue / Bed COMPUTED$108K
Net-to-Gross HCRIS57.6%
Distress Probability MLnan%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
113
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of -32.9% places it below the state median. Among 113 size-comparable peers (12-48 beds), the median margin is -20.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-48), prioritizing same-state peers. 113 hospitals in the comp set.

HospitalStateBedsRevenueMargin
FREEDOM BEHAVIORAL HOSPITAL OF (Target)KS24$2.6M-32.9%
CHILDRENS MERCY HOSPITAL KANSAKS42$108.5M14.7%
KANSAS CITY ORTHOPAEDIC INSTITKS17$86.3M21.1%
NEWMAN REGIONAL HEALTHKS23$73.9M-15.6%
KANSAS SPINE & SPECIALTY HOSPIKS35$69.6M19.1%
KANSAS SURGERY & RECOVERY CENTKS30$62.8M20.0%
VIA CHRISTI HOSP. WICHITA ST. KS38$55.1M16.7%
UKHS GREAT BEND CAMPUSKS29$53.8M-22.8%
NEOSHO MEMORIAL REGIONAL MED CKS21$53.8M-13.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $205K (793bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$58K+224bp12mo
Net Collection Rate93.5%97.0%$54K+210bp18mo
Cost to Collect4.5%2.5%$52K+200bp12mo
A/R Days Reduction5200.0%3800.0%$31K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+37bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$58K
Net Collection Rate
$54K
Cost to Collect
$52K
A/R Days Reduction
$31K
Clean Claim Rate
$10K
Total EBITDA Uplift$205K
Current EBITDA$-852K
+ RCM Uplift+$205K
Pro Forma EBITDA$-646K
Current Margin-32.9%
Pro Forma Margin-25.0%
WC Released (1x)$99K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.3M$-3.6M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.3M$-4.3M0.00x-100.0%
Bull Case9.0x11.0x$-1.2M$-4.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.2M$-4.8M0.00x-100.0%
Bear Case11.0x10.0x$-1.4M$-4.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.4M$-5.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 113 hospitals with 12-48 beds
  • Same-state prioritization (n=114)
  • Comp margins: P25=-30.8% / P50=-20.6% / P75=-10.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.